| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/04/1999 | CN1225092A New substituted pyridyl keto enols |
| 08/03/1999 | US5932749 Asymmetric synthesis of R-α-propyl-piperonyl amine and its analogs |
| 08/03/1999 | US5932742 Chemical intermediate to active antitumor agent |
| 08/03/1999 | US5932741 Treating illnesses resulting from abnormal stimulation of endothelin receptors |
| 08/03/1999 | US5932739 Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta 6,!benzofurans |
| 08/03/1999 | US5932730 Endothelin antagonist |
| 08/03/1999 | US5932725 Chromene compound |
| 08/03/1999 | US5932707 Thioether-containing metal chelating compounds |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932594 3-substituted piperidine derivative |
| 08/03/1999 | US5932571 Histamine receptor antagonists and tachykinin receptor antagonists. |
| 08/03/1999 | US5932566 Ansamycin derivatives as antioncogene and anticancer agents |
| 08/03/1999 | US5932538 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/03/1999 | CA2182101C Neuroprotective compounds |
| 08/02/1999 | CA2260568A1 Oxopiperazinyl derivatives and light stabilized compositions |
| 07/29/1999 | WO1999037651A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037640A1 Oxygenic heterocyclic compounds |
| 07/29/1999 | WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/29/1999 | WO1999037636A1 Heterocyclyl-derivatives |
| 07/29/1999 | WO1999037635A1 Quinoline derivatives as antibacterials |
| 07/29/1999 | WO1999037631A1 Novel taxaneterpine compounds |
| 07/29/1999 | WO1999037627A1 Substituted aminoalkylidenamino triazines as herbicides |
| 07/29/1999 | WO1999037625A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/29/1999 | WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037617A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037615A1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine |
| 07/29/1999 | WO1999037614A1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 07/29/1999 | WO1999037611A1 Heterocyclic amidines as callicrein protease inhibitors |
| 07/29/1999 | WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| 07/29/1999 | WO1999037297A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 07/29/1999 | WO1999020606A3 Piperidines and piperazines as platelet aggregation inhibitors |
| 07/29/1999 | DE19802449A1 Preparation of 3-hydroxy-1-methyl-4-phenyl-piperidine derivative isomer, for use as intermediate for antitumor agent flavopiridol |
| 07/29/1999 | DE19802236A1 New amino alkylidene-substituted triazines, useful as herbicides |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318842A1 Quinoline derivatives as antibacterials |
| 07/29/1999 | CA2318100A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318096A1 Substituted aminoalkylidenamino triazines as herbicides |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317546A1 2,3,4,5-tetrahydro-1h-¬1,4|-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/28/1999 | EP0931080A1 Amorphous paroxetine composition |
| 07/28/1999 | EP0931079A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/28/1999 | EP0931078A1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| 07/28/1999 | EP0931072A1 1-sulfonyl-3-phenylpyrazoles and their use as herbicides and for desiccating or defoliating plants |
| 07/28/1999 | EP0931067A1 D4 receptor selectivity piperazine derivatives |
| 07/28/1999 | EP0930883A1 Neurotrophin antagonist compositions |
| 07/28/1999 | EP0760368B1 Pyrimidine derivatives |
| 07/28/1999 | EP0737189B1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/28/1999 | EP0604494B1 5-ht4 receptor antagonists |
| 07/28/1999 | CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/27/1999 | US5929106 Vasodilator; hypotensive agent |
| 07/27/1999 | US5929103 Anticarcinogenic agents |
| 07/27/1999 | US5929097 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/27/1999 | US5929094 Novel 3-((substituted) heterocycle),6-(substituted phenyl)-1-oxaspiro(4.4)nonane derivatives; antagonizing the effect of substance p by administering to block neurokinin-1 receptors; treating inflammation, migraine, emesis and asthma |
| 07/27/1999 | US5929084 Treating myasthenia by inhibiting cholinesterase comprising administering huperazine a derivative to the patient |
| 07/27/1999 | US5929075 Apolipoprotein-B synthesis inhibitors |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells |
| 07/27/1999 | US5928999 Substituted 3-phenylpyrazoles |
| 07/27/1999 | US5928998 Arylindazoles and their use as herbicides |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/22/1999 | WO1999036416A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
| 07/22/1999 | WO1999036410A1 Triazine antiviral compounds |
| 07/22/1999 | WO1999024870A3 Compound, composition and use |
| 07/22/1999 | DE19801646A1 New bicyclic lactone glutamate receptor modulators for treating cerebral ischemia, cranial/brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | CA2318362A1 Triazine antiviral compounds |
| 07/21/1999 | EP0930309A1 Taxane derivatives and drugs containing the same |
| 07/21/1999 | EP0930301A1 2-Fluoropyridine, process for producing it and its use in liquid crystal mixtures |
| 07/21/1999 | EP0930298A1 Fluorinated 1,4-disubstituted piperidine derivatives |
| 07/21/1999 | EP0930291A1 Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers |
| 07/21/1999 | EP0930075A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 07/21/1999 | EP0929551A1 New pharmaceutically active compounds |
| 07/21/1999 | EP0929548A1 Substituted carbamoyl triazoles and their use as herbicides |
| 07/21/1999 | EP0929545A1 Tricyclic inhibitors of farnesyl protein transferase |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 07/21/1999 | EP0929299A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS |
| 07/21/1999 | CN1223652A Cyclic ether compounds as sodium channel modulators |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/21/1999 | CN1223592A Fluoro labelled anthracyclinone and anthracycline derivatives |
| 07/21/1999 | CN1223259A Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof |
| 07/21/1999 | CN1044244C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925770 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/20/1999 | US5925650 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 07/20/1999 | US5925648 Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925631 Alkylated styrenes as prodrugs to COX-2 inhibitors |
| 07/20/1999 | CA2007200C 2-aminopyrimidinone derivatives |
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035143A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | WO1999035118A1 Ester compounds, liquid crystal compositions and liquid crystal display devices |
| 07/15/1999 | DE19800214A1 Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür Process for the preparation of doxazosin Mcsylat in a crystal form known as Form A and an intermediate therefor |
| 07/15/1999 | CA2317523A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/14/1999 | EP0777649B1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor agonists |
| 07/14/1999 | EP0696282B1 Process for preparing intermediates for the synthesis of antifungal agents |